Login / Signup
Switching from natalizumab to alemtuzumab in patients with relapsing multiple sclerosis.
Nevin A John
Antonia Carroll
Wallace J Brownlee
Jeremy Chataway
Published in:
Journal of neurology, neurosurgery, and psychiatry (2019)
Keyphrases
</>
multiple sclerosis
white matter
rheumatoid arthritis
disease activity